GaryStevenSachsMD

Psychiatry • Boston, MA

Addiction

Associate Clinical Professor of Psychiatry, Massachusetts General Hospital

Join to view full profile

Dr. Sachs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sachs' full profile

Already have an account?

Office
15 Parkman St
Wac 8
Boston, MA 02114
Phone+1 617-724-6544

Fax+1 617-726-6768

Education & Training

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1983 - 1986
University of Maryland/Sheppard PrattResidency, Psychiatry, 1982 - 1982
University of Maryland School of MedicineClass of 1982

Certifications & Licensure

CA State Medical License 1988 - Present
MA State Medical License 1984 - 2025
FL State Medical License 2019 - 2021
MD State Medical License 1983 - 1983
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Start of enrollment: 1998 Sep 01
Completed
Not Applicable
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression Start of enrollment: 2008 Nov 01
Completed
Phase 2

Publications & Presentations

PubMed

1010 citations
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
Robert M. A. Hirschfeld, Janet B.W. Williams, Robert L. Spitzer, Joseph R. Calabrese, Laurie M. Flynn
The American Journal of Psychiatry. 2000-11-01
101 citations
An open-label trial of divalproex in children and adolescents with bipolar disorder.
Karen Dineen Wagner, Elizabeth B. Weller, Gabrielle A. Carlson, Gary S. Sachs, Joseph Biederman
Journal of the American Academy of Child and Adolescent Psychiatry. 2002-10-01
111 citations
Bipolar depression: pharmacotherapy and related therapeutic strategies
Michael E. Thase, Gary S. Sachs
Biological Psychiatry. 2000-09-15

Lectures

Antidepressants in Bipolar Disorder: STEP into the Light
161st Annual Meeting, Washington, DC, USA
Antidepressants in Bipolar Disorder: STEP into the Light
American Psychiatric Association, 161st Annual Meeting, Washington, DC, USA

Press Mentions

U.S. FDA Approves VRAYLAR® (Cariprazine) as an Adjunctive Treatment for Major Depressive DisorderDecember 17th, 2022
Antipsychotic Safe, Effective for Resistant Depression in Phase 3 TrialMay 26th, 2022
Add-on Vraylar Tied to Easing of Recurrent Depressive SymptomsMay 22nd, 2022
Join now to see all

Grant Support

Pilot Study Of A Calcium Channel Blocker In FemalesNational Institute Of Mental Health1999–2000
Treatment Of Bipolar DisorderNational Institute Of Mental Health1998–2000